Growth Metrics

Boston Scientific (BSX) Long-Term Debt Issuances (2016 - 2025)

Boston Scientific (BSX) has disclosed Long-Term Debt Issuances for 14 consecutive years, with $1.6 billion as the latest value for Q1 2025.

  • Quarterly Long-Term Debt Issuances fell 27.37% to $1.6 billion in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 billion through Dec 2025, down 27.37% year-over-year, with the annual reading at $1.6 billion for FY2025, 27.37% down from the prior year.
  • Long-Term Debt Issuances hit $1.6 billion in Q1 2025 for Boston Scientific, down from $2.1 billion in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $3.3 billion in Q1 2022 to a low of -$1.0 million in Q2 2022.
  • Historically, Long-Term Debt Issuances has averaged $1.7 billion across 3 years, with a median of $1.9 billion in 2024.
  • Biggest YoY gain for Long-Term Debt Issuances was 27.37% in 2025; the steepest drop was 27.37% in 2025.
  • Year by year, Long-Term Debt Issuances stood at -$1.0 million in 2022, then surged by 214600.0% to $2.1 billion in 2024, then decreased by 27.37% to $1.6 billion in 2025.
  • Business Quant data shows Long-Term Debt Issuances for BSX at $1.6 billion in Q1 2025, $2.1 billion in Q1 2024, and -$1.0 million in Q2 2022.